Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

NICE backs world’s most expensive medicine

September 4, 2014 Sales and Marketing AGNSS, Alexion, England, NICE, aHUS, solaris

In a U-turn on its previous guidance NICE is now recommending that the £330,000 rare disease drug Soliris should be …
News

Mixed results for AZ’s troubled Brilinta

September 3, 2014 Sales and Marketing AstraZeneca, Brilinta, EMA, PCI, atlantic, heart, stent

The latest trial for AstraZeneca’s heart drug Brilinta (ticagrelor) has failed to meet expected results but suggests more flexible applications …
News

Should patients be able to email their general practitioner?

September 3, 2014 Medical Communications, Sales and Marketing BMJ, GPs, clinicians, econsultations, email

Email consultations with your doctor make better use of their time and are more convenient, or threaten safety and create …
News

BioData appoints new chief executive

September 3, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Louis Culot, biodata, culot

Digital science portfolio firm BioData that produces web-based research and lab management service Labguru, has appointed Louis Culot as its …
Appointment

NICE: Cancer Drugs Fund must use our processes

September 3, 2014 Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, David Haslam, Kadcyla, NICE, Roche

NICE believes that the Cancer Drugs Fund should be aligned with its cost-effectiveness processes, after the government recently announced a …
News

Novo Nordisk scraps inflammatory disorders business

September 2, 2014 Research and Development, Sales and Marketing Danish, IL20, Novo Nordisk, diabetes, inflammatory, thomsen

A restructuring of Novo Nordisk will see it completely drop its inflammatory disorders activities in favour of concentrating on its …
News

EMA hires head of comms and HR

September 2, 2014 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Manuel Ortigão, Marie-Agnes Heine

The European Medicines Agency has confirmed two new appointments to join its management team.  Marie-Agnes Heine (pictured) has joined to …
Appointment

Children’s cancer death rates drop

September 2, 2014 Medical Communications, Research and Development, Sales and Marketing CRUK, Cancer, Cancer Research UK, child, death rates

The rate of children dying from cancer has dropped by 22% in the last decade, according to new data published …
News

Ben Venue problems continue for Boehringer

September 2, 2014 Manufacturing and Production, Sales and Marketing Ben Venue, Boehringer, fad, german, manufacturing, recall

Boehringer Ingelheim’s tribulations at its US production site Ben Venue Laboratories are refusing to leave as more of its products …
News

BioNTech appoints chief financial officer

September 2, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BioNTech, Sierk Pötting

German biopharma firm BioNTech has announced that Sierk Pötting will be joining its management team as its chief financial officer, …
Appointment

NHS proton beam therapy refusal led to child patient disappearance

September 1, 2014 Sales and Marketing Ashya King, Cancer, NHS, proton beam

The parents of child cancer patient Ashya King say they took him from hospital because NHS doctors would not offer …
News

AZ shares climb on positive cancer drug news

September 1, 2014 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Pfizer, immunoc-oncology, pd-1

AstraZeneca has moved a key new oncology drug into mid-stage trials as it looks to shore up its cancer research …
News

China: a dangerous game that pharma must play

September 1, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GSK, chinese, emerging, market access, pharma, susie lunt

Set to be the biggest country for pharma growth in the 21st century, with rising levels of chronic disease, an …
Feature

Novartis heart drug sees stellar results

September 1, 2014 Sales and Marketing Diovan, LCZ696, Novartis, failure, heart, valsartan

Novartis’ new heart pill has produced stellar results in helping patients with heart failure live longer, making it the first …
News

Biogen Idec hires from Novartis to head ALS

September 1, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen IDEC, Novartis, als, donald johns

Biogen Idec has appointed Dr Donald Johns as the vice president of its amyotrophic lateral sclerosis (ALS) innovation hub unit. …
Appointment
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026